Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 0.350
- +0.150+75.00%
15min DelayClose Apr 4 16:00 ET
- 0.350
- 0.0000.00%
Post 16:30 ET
434.88KMarket Cap0.00P/E (TTM)
0.450High0.130Low148.80KVolume0.200Open0.200Pre Close29.94KTurnover12.08%Turnover Ratio0.00P/E (Static)1.24MShares101.32052wk High-0.48P/B431.05KFloat Cap0.13052wk Low--Dividend TTM1.23MShs Float9000.000Historical High--Div YieldTTM160.00%Amplitude0.130Historical Low0.201Avg Price1Lot Size
About Virpax Pharmaceuticals Company
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Company Profile
SymbolVRPX
Company NameVirpax Pharmaceuticals
Issue Price10.00
CEOMr. Jatinder Dhaliwal
MarketPink Market
Employees2
Fiscal Year Ends12-31
Websitehttps://www.virpaxpharma.com
Company Executives
- Name
- Position
- Salary
- Jatinder Dhaliwal
- Director and Chief Executive Officer
- --
- Usama Chaudhry
- Chief Financial Officer and Corporate Secretary
- --
- Dr. Sheila A. Mathias, J.D.,M.B.A.,PhD
- Chief Scientific Officer
- 498.00K
- Katharyn Field
- Director
- --
- Charn Deol
- Independent Director
- --
- Judy Su
- Independent Director
- --
- Esha Randhawa
- Independent Director
- --
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now